US 8071323
Human monoclonal antibodies that bind human insulin like growth factors and their use
granted A61KA61K47/6817A61K47/6843
Quick answer
US patent 8071323 (Human monoclonal antibodies that bind human insulin like growth factors and their use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 52
- CPC classes
- A61K, A61K47/6817, A61K47/6843, A61K51/1018, A61P